Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM - Nebido®)

Clinical Endocrinology

Volumn 69, Issue 4, 2008, Pages 642-647

  Moisey, Robert ^a   Swinburne, Julie ^a   Orme, Steve ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; AGED; ARTICLE; BIOAVAILABILITY; BODY MASS; BODY SIZE; BODY SURFACE; BODY WEIGHT; DRUG EFFICACY; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOLOGICAL AVAILABILITY; BODY SIZE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOGONADISM; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TESTOSTERONE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 51649103492     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03251.x     Document Type: Article

References (29)

1. Behre, H.M., Abshagen, K., Oettel, M., Hübler, D. Nieschlag, E. (1999) Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. European Journal of Endocrinology, 140, 414 419.
2. Schubert, M., Minnemann, T., Hübler, D., Rouskova, D., Christoph, A., Oettel, M., Ernst, M., Mellinger, U., Krone, W. Jockenhövel, F. (2004) Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. Journal of Clinical Endocrinology and Metabolism, 89, 5429 5434.
3. Von Eckardstein, S. Nieschlag, E. (2002) Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study. Journal of Andrology, 23, 419 425.
4. Bayer Schering Pharma, Bayer plc 2006) Bayer House, Strawberry Hill, Newbury. RG14 1JA. Nebido 1000mg/4ml, for injections. Summary of Product Characteristics, November 2006.
5. Taieb, J., Mathian, B., Millot, F., Patricot, M.C., Mathieu, E., Queyrel, N., Lacroix, I., Somma-Delpero, C. Boudou, P. (2003) Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clinical Chemistry, 49, 1381 1395.
6. Wang, C., Catlin, D.H., Demers, L.M., Starcevic, B. Swerdloff, R.S. (2004) Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 89, 534 543.
7. Cawood, M.L., Field, H.P., Ford, C.G., Gillingwater, S., Kicman, A., Cowan, D. Barth, J.H. (2005) Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice. Clinical Chemistry, 51, 1472 1479.
8. Dunn, J.F., Nisula, B.C. Rodbard, D. (1981) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism, 53, 58 68.
9. Vermeulen, A., Kaufman, J.M. Giagulli, V.A. (1996) Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. Journal of Clinical Endocrinology and Metabolism, 81, 1821 1826.
10. Muller, M., den Tonkelaar, I., Thijssen, J.H., Grobbee, D.E. van der Schouw, Y.T. (2003) Endogenous sex hormones in men aged 40-80 years. European Journal of Endocrinology, 149, 583 589.
11. Hampl, R., Kancheva, R., Hill, M., Bičíková, M. Vondra, K. (2003) Interpretation of sex hormone-binding globulin levels in thyroid disorders. Thyroid, 13, 755 760.
12. Giavoli, C., Ferrante, E., Ermetici, F., Bergamaschi, S., Ronchi, C.L., Lania, A.G., Ambrosi, B., Spada, A. Beck-Peccoz, P. (2006) Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency. Clinical Endocrinology, 65, 717 721.
13. Hautanen, A., Sarna, S., Pelkonen, R. Adlercreutz, H. (1993) Serum sex hormone-binding globulin, cardiovascular risk factors, and adrenal cortisol responses to dexamethasone and corticotropin. Metabolism, 42, 870 874.
14. de Ronde, W., van der Schouw, Y.T., Pols, H.A., Gooren, L.J., Muller, M., Grobbee, D.E. de Jong, F.H. (2006) Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. Clinical Chemistry, 52, 1777 1784.
15. Giton, F., Fiet, J., Guéchot, J., Ibrahim, F., Bronsard, F., Chopin, D. Raynaud, J.P. (2006) Serum bioavailable testosterone: assayed or calculated? Clinical Chemistry, 52, 474 481.
16. DuBois, D. DuBois, E.F. (1916) A formula to estimate the approximate surface area if height and weight be known. Archives of Internal Medicine, 17, 863 871.
17. Morris, P.D., Malkin, C.J., Channer, K.S. Jones, T.H. (2004) A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. European Journal of Endocrinology, 151, 241 249.
18. Nieschlag, E., Büchter, D., Von Eckardstein, S., Abshagen, K., Simoni, M. Behre, H.M. (1999) Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clinical Endocrinology, 51, 757 763.
19. Morley, J.E., Kaiser, F.E., Perry, H.M. III, Patrick, P., Morley, P.M., Stauber, P.M., Vellas, B., Baumgartner, R.N. Garry, P.J. (1997) Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism: Clinical and Experimental, 46, 410 413.
20. Feldman, H.A., Longcope, C., Derby, C.A., Johannes, C.B., Araujo, A.B., Coviello, A.D., Bremner, W.J. McKinlay, J.B. (2002) Age trends in the level of serum testosterone and other hormones in middle aged men: longitudinal results from the Massachusetts male aging study. Journal of Clinical Endocrinology and Metabolism, 87, 589 598.
21. Bhasin, S., Cunningham, G.R., Hayes, F.J., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S. Montori, V.M. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 91, 1995 2010.
22. Mohr, B.A., Guay, A.T., O'Donnell, A.B. McKinlay, J.B. (2005) Normal, bound and non-bound testosterone levels in normally ageing men: results from the Massachusetts male ageing study. Clinical Endocrinology, 62, 64 73.
23. Mathor, M.B. Wajchenberg, B.L. (1985) A simplified method for the calculation of unbound or free testosterone by equilibrium dialysis of undiluted plasma. Clinica Chimica Acta, 145, 213 218.
24. Hammond, G.L., Nisker, J.A., Jones, L.A. Siiteri, P.K. (1980) Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. Journal of Biological Chemistry, 255, 5023 5026.
25. Vermeulen, A., Verdonck, L. Kaufman, J.M. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism, 84, 3666 3672.
26. Van Uytfanghe, K., Stockl, D., Kaufman, J.M., Fiers, T., De Leenheer, A. Thienpont, L.M. (2005) Validation of 5 routine assays for serum free testosterone with a candidate reference measurement procedure based on ultrafiltration and isotope dilution-gas chromatographymass spectrometry. Clinical Biochemistry, 38, 253 261.
27. Heald, A.H., Anderson, S.G., Ivison, F., Riste, L., Laing, I., Cruickshank, J.K. Gibson, J.M. (2005) Low sex hormone binding globulin is a potential marker for the metabolic syndrome in different ethnic groups. Experimental and Clinical Endocrinology and Diabetes, 113, 522 528.
28. van den Beld, A.W., de Jong, F.H., Grobbee, D.E., Pols, H.A. Lamberts, S.W. (2000) Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. Journal of Clinical Endocrinology and Metabolism, 85, 3276 3282.
29. Mohr, B.A., Bhasin, S., Link, C.L., O'Donnell, A.B. McKinlay, J.B. (2006) The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts male aging study. European Journal of Endocrinology, 155, 443 452.